Here, we report the effects of short exposure to melatonin on the human mt 1 (h mt 1 ) melatonin receptor-mediated signaling in Chinese hamster ovary (CHO) cells, and the consequences of an exposure that resembles the physiological pattern of melatonin release on cAMPmediated signal transduction. Short exposure (10 min) of h mt 1 melatonin receptors to melatonin (400 pM) inhibited forskolin-stimulated cAMP formation, cAMP-dependent protein kinase activity, and phosphorylation of the cAMP response element-binding protein. However, treatment of mt 1 -CHO cells with melatonin in a manner that closely mimics the in vivo activation of melatonin receptors (i.e. 400 pM melatonin for 8 h to mimic darkness) resulted in a supersensitization of the cAMP-dependent signal transduction cascade during the period of withdrawal (i.e. 16 h without melatonin to mimic the light cycle of a diurnal photoperiod). During the period of withdrawal, forskolin induced a time-dependent (1-16 h) increase in cAMP formation (ϳ200% of control cells). This effect of melatonin was dependent on the presence of the h mt 1 melatonin receptor, as no potentiation of forskolin-induced cAMP formation was observed in CHO cells transfected only with the neomycin resistance plasmid. The time-dependent increase in forskolin-stimulated cAMP levels resulted in a potentiation of cAMP-dependent protein kinase activity 1 h after withdrawal (ϳ130% of control cells; P Ͻ 0.05) and in the number of cells containing the phosphorylated form of cAMP response elementbinding protein (ϳ75% of cells at 1 and 16 h compared with 30% in control cells; P Ͻ 0.05). An increase in the undissociated state (G␣␤␥) of G i proteins may underlie this phenomenon as demonstrated by the increase in pertussis toxin-catalyzed ADP-ribosylation of G proteins (217 Ϯ 48% of control; P Ͻ 0.05) after melatonin withdrawal. This increase in the ribosylation was not due to an up-regulation of G␣ i protein, as no significant change in G␣ i protein levels occurred at this time. We demonstrated that activation of the h mt 1 melatonin receptor in a manner that resembles the physiological pattern of melatonin exposure alters signaling, as potentiation of cAMP-mediated signal transduction events is observed after hormone withdrawal. The CHO cells expressing the human melatonin receptor may provide an in vitro cellular model in which to investigate the putative signaling mechanisms leading to gene regulation by melatonin. (Endocrinology 139: 3064 -3071, 1998) M ELATONIN, a hormone produced by the pineal gland and retina, is released with a circadian rhythm, with high levels at night. It mediates physiological responses via activation of high affinity melatonin receptors (1, 2). In hamster hypothalamus (3) and in intact sheep pars tuberalis cells (4), activation of high affinity melatonin receptors inhibits forskolin-induced cAMP formation via pertussis toxinsensitive G proteins. In native tissues, melatonin inhibits forskolin-stimulated cAMP-dependent protein kinase (PKA) activity (5) and phosphorylation of cAMP response elementbinding protein (CREB) (6).
dent increase in forskolin-stimulated cAMP levels resulted in a potentiation of cAMP-dependent protein kinase activity 1 h after withdrawal (ϳ130% of control cells; P Ͻ 0.05) and in the number of cells containing the phosphorylated form of cAMP response elementbinding protein (ϳ75% of cells at 1 and 16 h compared with 30% in control cells; P Ͻ 0.05). An increase in the undissociated state (G␣␤␥) of G i proteins may underlie this phenomenon as demonstrated by the increase in pertussis toxin-catalyzed ADP-ribosylation of G proteins (217 Ϯ 48% of control; P Ͻ 0.05) after melatonin withdrawal. This increase in the ribosylation was not due to an up-regulation of G␣ i protein, as no significant change in G␣ i protein levels occurred at this time. We demonstrated that activation of the h mt 1 melatonin receptor in a manner that resembles the physiological pattern of melatonin exposure alters signaling, as potentiation of cAMP-mediated signal transduction events is observed after hormone withdrawal. The CHO cells expressing the human melatonin receptor may provide an in vitro cellular model in which to investigate the putative signaling mechanisms leading to gene regulation by melatonin. (Endocrinology 139: 3064 -3071, 1998) M ELATONIN, a hormone produced by the pineal gland and retina, is released with a circadian rhythm, with high levels at night. It mediates physiological responses via activation of high affinity melatonin receptors (1, 2) . In hamster hypothalamus (3) and in intact sheep pars tuberalis cells (4) , activation of high affinity melatonin receptors inhibits forskolin-induced cAMP formation via pertussis toxinsensitive G proteins. In native tissues, melatonin inhibits forskolin-stimulated cAMP-dependent protein kinase (PKA) activity (5) and phosphorylation of cAMP response elementbinding protein (CREB) (6) .
Prolonged exposure of pars tuberalis cells maintained in culture to melatonin leads to desensitization of melatonin receptors and potentiation of forskolin-mediated cAMP accumulation (4) . The recombinant human mt 1 (h mt 1 ) 1 melatonin receptor expressed in cell lines, which also signals through inhibition of forskolin-stimulated cAMP formation (7, 8) , offers an in vitro model in which to study the regulation of signaling upon physiological exposure to melatonin, i.e. concentration and time. The synthesis and secretion of melatonin occur in a rhythmic fashion, with blood levels of 1 Here we use the official nomenclature and classification of melatonin receptors approved by the nomenclature committee of the International Union of Pharmacology (42) . The denomination mt 1 corresponds to that of the recombinant melatonin receptor subtype previously known as Mel 1a (11) , which does not show well defined functional characteristics. The mt 2 recombinant receptor, previously known as Mel 1b , is referred to here as MT 2 because it has a defined function and was pharmacologically characterized in a native tissue (43). MT 3 corresponds to the pharmacologically defined melatonin receptor subtype, with unknown molecular structure, previously referred to as ML 2 (44) . melatonin being highest during the night (ϳ100 pg/ml) and lowest during the day (ϳ10 pg/ml) in humans (9) and many other species (10) . Here, we report the effects of physiological exposure of mt 1 melatonin receptors expressed in Chinese hamster ovary (CHO) cells to melatonin at different points along the cAMP-dependent signal transduction cascade, that is on G protein function, cAMP formation, PKA activation, and phosphorylation of the transcription factor CREB. We conclude that the physiological activation of the human mt 1 melatonin receptor potentiates cAMP-mediated signal transduction events after hormone withdrawal.
Materials and Methods

Development of a stable CHO cell line expressing the h mt 1 melatonin receptor
A stable CHO cell line expressing the h mt 1 melatonin receptor (11) was developed as previously described (7) . CHO cells expressing the neomycin resistance plasmid (pSV-Neo) alone were used as controls. The cell line used in this study originated from a single cell selected using the limited dilution protocol. The affinity of [2- 125 I]iodomelatonin binding for the h mt 1 melatonin receptor in this cell line is 74 Ϯ 14 pm, and the binding capacity is 679 Ϯ 88 fmol/mg protein. The affinities of melatonin for competition with [2- 125 I]iodomelatonin binding to the h mt 1 melatonin receptor were: IC 50SH , 6.5 pm; and IC 50H , 2 nm (7).
Melatonin pretreatment and withdrawal
pSV-Neo CHO and mt 1 -CHO cells were grown to confluence in the presence of 10% FBS. Cells were refed with Ham's F-12 medium without serum and maintained in culture in the absence (vehicle, 0.000001% ethanol) or presence of melatonin (in vehicle, 400 pm) for 8 h. At the end of this incubation period, the F-12 medium from control or melatonintreated cells was removed, and the cells were refed with fresh F-12 media. At various times after melatonin withdrawal (0, 1, 2, 4, 8, 12, and 16 h) or 16 h after vehicle removal (control cells), the following measurements were performed: ADP ribosylation and immunoblot analyses of G proteins, forskolin-induced cAMP accumulation, cAMP-dependent protein kinase activity, and immunocytochemical measurements of CREB phosphorylation.
cAMP accumulation assays
cAMP accumulation assays were carried out as previously described (7) . Briefly, forskolin-induced [ 3 H]cAMP accumulation was measured in pSV-Neo CHO cells and mt 1 -CHO cells. Cells, grown to confluence, were reincubated with F-12 medium containing 2 Ci/ml [ 3 H]adenine (26.9 Ci/mmol; New England Nuclear-DuPont, Boston, MA) in the absence (containing vehicle) or presence of melatonin (400 pm) for 8 h. The medium containing melatonin was aspirated, and the cells were reincubated with F-12 medium containing 1 Ci/ml [ 3 H]adenine. At various times after melatonin withdrawal, cAMP formation was stimulated by the addition of F-12 medium containing 100 m forskolin (Sigma Chemical Co., St. Louis, MO) and 30 m rolipram (RBI, Natick, MA). The plates were incubated for 10 min at 37 C, and the reaction was terminated by aspiration of the medium and addition of 1 ml ice-cold (5%) trichloroacetic acid (16 
PKA assays
PKA assays were carried out as described previously (12) . After the melatonin treatment and withdrawal periods, cells were washed twice with PBS without calcium or magnesium (PBS; 137 mm NaCl, 2. 
Immunocytochemical determination of the phosphorylation of CREB
These assays were performed with slight modification as previously described (13) . Pretreatment with melatonin was carried out exactly as described for adenylyl cyclase assays, except that cells were grown on coverslips. After melatonin treatments and withdrawal periods, cells were stimulated with 100 m forskolin and 30 m rolipram. After 10-min incubation at 37 C, the medium was removed, and cells were fixed in 4% paraformaldehyde for 30 min at room temperature and rinsed three times at 5-min intervals with PBS containing 10 mm glycine (PBS-gly). Cells were then permeabilized in 0.3% Triton X-100 in PBS-gly containing 2% goat serum (Vectastain ABC Kit, Vector Laboratories, Burlingame, CA) for 30 min at room temperature to reduce nonspecific staining. After permeabilization and blocking, cells were incubated in 0.3% Triton X-100, in PBS-gly containing no primary antibody (nonspecific staining) or with a 1:500 dilution of antirat phosphorylated CREB antibody (Upstate Biotechnology, Lake Placid, NY) for 16 h at 4 C. Wells that received only secondary antibody showed no staining above background (data not shown). The following day, all coverslips were rinsed in PBS-gly three times at 5-min intervals and then incubated in 0.3% Triton X-100 in PBS-gly containing antirabbit IgG secondary antibody (1:1000) for 30 min at 37 C (Vectastain ABC Kit). Coverslips were rinsed in PBS-gly three times at 5-min intervals and then incubated with diaminobenzidine-peroxidase (Vector Laboratories). When color developed, the reaction was terminated by extensive washing in tap water. Cells were dehydrated, rinsed for 1 h, and mounted using Permount (Fisher Scientific, Fairlawn, NJ). Cells were imaged using a light microscope attached to an LCD video camera, projected onto a computer screen using Metamorph imaging software (Universal Imaging Corp., WestChester, PA), and then quantitated by NIH Image software (Wayne Rasband, NIH, Bethesda, MD).
ADP ribosylation analysis
All ribosylation assays were performed according to the methods previously described (14) . Cells were grown to confluence on 10-cm dishes. After the treatment and withdrawal periods, the cells were washed twice with PBS and centrifuged at 600 ϫ g for 10 min. The cells were then resuspended in buffer [2 mm Tris-HCl (pH 7.5), 1 mm EDTA, 0.2 m DTT, 10 g/ml leupeptin, 0.2 mm phenylmethylsulfonylfluoride, and 10 g/ml aprotinin], homogenized using a Polytron, and pelleted by centrifugation at 15,000 ϫ g for 30 min. The resulting pellet was suspended in 500 l buffer [10 mm Tris-HCl (pH 7.7), 1 mm MgCl 2 , and 0.1 mm EDTA]. Fifty micrograms of membrane protein were incubated at 32 C for 1 h with 0.2 mg/ml thiol-preactivated cholera toxin or 20 g/ml thiol-preactivated pertussis toxin (Calbiochem, La Jolla, CA) in buffer containing 10 m [␣-
32 P]NAD (3.3 Ci/mmol). Labeled membranes were then washed in ice-cold buffer, solubilized, and subjected to 10% PAGE. After electrophoresis, gels were dried and exposed to x-ray film. 32 P incorporation into the M r 46,000 protein band (cholera toxin) and the M r 41,000 band (pertussis toxin) was quantified by integrating densitometric scans.
Immunoblot analysis
Cells collected during the period of melatonin withdrawal were used to prepare membrane proteins (50 g), which were separated by SDS-PAGE, electrotransferred to nitrocellulose filters, and analyzed by immunoblotting. Nonspecific binding sites on the nitrocellulose filters were blocked for 1 h at room temperature in 5% nonfat dry milk and dissolved in Tris-buffered saline. G␣ i and G␣ s proteins were detected by antirabbit G␣ i antiserum (1:500), which detects G␣ i1 ϭ G␣ i2 Ͼ G␣ i3 (provided by Dr. David Manning, University of Pennsylvania School of Medicine, Philadelphia, PA) (15, 16) or with antirabbit G␣ s (1:1000; a gift from Mark Rasenick, University of Illinois, Chicago, IL) in milk-Trisbuffered saline, respectively. After five rinses in Tris-buffered saline, the filters were incubated with a 1:5000 dilution of goat antirabbit IgGhorseradish peroxidase (Pierce Chemical Co., Rockford, IL) for 1 h at room temperature. G Protein bands were detected by enhanced chemiluminescence (Amersham, Arlington Heights, IL). Filters were exposed to Hyperfilm (Amersham). For quantitation, films were scanned with a densitometer and quantitated using the Molecular Analyst System (BioRad, Hercules, CA). PKA activity was expressed as activity ratios where the basal activity or the activity induced by a submaximal concentration of forskolin (10 m) was divided by the total PKA activity induced by 5 m cAMP. PKA activity ratios were then expressed as a percentage of the basal response or as a percentage of the forskolin-induced response in control cells for 8-h melatonin treatment experiments.
Data analysis
The intensity of nuclear phosphorylated CREB immunocytochemical staining was assessed in each experiment by measuring the relative OD value above the threshold. A set threshold value was assigned to a nucleus that had no immunocytochemical staining for each set of experiments. Nuclei that had OD values less than the threshold value were rated as having undergone no immunocytochemical staining, and nuclei that had OD values greater than the threshold value were rated as having undergone immunocytochemical staining. Nuclei that had immunocytochemical staining above background were then divided by the total number of nuclei analyzed. Statistical analyses were performed by one-way ANOVA or repeated measures ANOVA using GraphPad Prism (San Diego, CA). Significance is defined as P Ͻ 0.05.
Results
Melatonin inhibits forskolin-stimulated increases in PKA activity and in the phosphorylation of CREB in mt 1 -CHO cells
Melatonin inhibits forskolin-mediated increases in cAMP formation in CHO cells expressing the human mt 1 melatonin receptor (7) . To further characterize the effect of mt 1 melatonin receptor activation on cAMP-mediated signaling, we studied the effects of this hormone on the activity of PKA and on the phosphorylation of the transcription factor CREB. Acute exposure to 400 pm melatonin (10 min) reduced basal PKA activity by 30% (Fig 1) . Stimulation with forskolin (10 m) for 10 min increased PKA activity to 139 Ϯ 10% (n ϭ 3) of the basal value in mt 1 -CHO cells. This increase in PKA activity was inhibited by simultaneous exposure to 400 pm melatonin for 10 min (105 Ϯ 7% of basal; n ϭ 3; Fig. 1 ). To assess whether the increase in protein kinase activity induced by forskolin in mt 1 -CHO cells activated the transcription factor CREB, we determined nuclear anti-phospho-CREB immunoreactivity by immunocytochemistry (Figs. 1B and 2 ). 
Forskolin-induced cAMP formation in mt 1 -CHO cells is increased after withdrawal of a physiological exposure to melatonin
Pretreatment of mt 1 -CHO cells with melatonin (400 pm; 8 h) followed by withdrawal of melatonin for up to 16 h resulted in a time-dependent increase in forskolin-induced cAMP formation, reaching a maximum by 4 h (approximately twice that accumulated in control cells; Fig. 3A ). This increase in forskolin-induced cAMP formation after melatonin withdrawal was mediated through the human mt 1 melatonin receptor. Pretreatment of pSV-Neo CHO cells with 400 pm melatonin followed by 16-h withdrawal did not affect forskolin-induced cAMP formation, whereas the same treatment increased cAMP formation in mt 1 -CHO cells to 244% of that in untreated cells (P Ͻ 0.05; Fig. 3B ).
Forskolin-stimulated PKA activity in mt 1 -CHO cells is increased after withdrawal of melatonin
Pretreatment of mt 1 -CHO cells with melatonin (400 pm) for 8 h followed by withdrawal (0, 1, and 16 h) resulted in an increase in 10 m forskolin-stimulated PKA activity (Fig. 4A ) with no change in total PKA activity that was induced by 5 m cAMP (Fig. 4B) . One hour after withdrawal, forskolin (10 m)-stimulated PKA activity increased to 141 Ϯ 8.1% of the activity observed in untreated cells (n ϭ 4; P Ͻ 0.05). The effect decreased to 128 Ϯ 13% of that in untreated cells 16 h after melatonin withdrawal (Fig. 4A) .
Forskolin-induced phosphorylation of CREB protein in mt 1 -CHO cells is increased after withdrawal of melatonin
To study whether the increase in forskolin-induced PKA activity after melatonin withdrawal was transduced to the level of the nucleus, the effect of prolonged exposure to melatonin on the phosphorylation of CREB was examined by immunocytochemistry (Figs. 4C and 5) . In untreated cells, stimulation by forskolin resulted in 33 Ϯ 6% of the cells containing the phosphorylated form of CREB. However, during melatonin withdrawal, the number of cells containing nuclear phospho-CREB immunoreactivity increased in a time-dependent manner, where levels of significance were reached after 1 h of melatonin withdrawal (74 Ϯ 9% of cells; n ϭ 4; P Ͻ 0.05) and remained elevated up to 16 h after withdrawal (77 Ϯ 13%; n ϭ 4; P Ͻ 0.05; Fig. 4C ).
Pertussis toxin-catalyzed ribosylation of G␣ i /G␣ o proteins is increased after withdrawal of melatonin
To determine whether alterations in G protein function or levels underlie this supersensitization phenomenon, ribosylation and immunoblot analyses were performed. The relative dissociation states of G proteins were assessed by measuring the relative magnitudes of pertussis and cholera toxin-catalyzed [ 32 P]ADP ribosylation of G proteins. Melatonin withdrawal did not significantly change the relative state of dissociation of Gs or the amount of Gs protein (data not shown). On the contrary, under these same treatment conditions, the amount of 32 P incorporated into G proteins after ADP ribosylation by pertussis toxin demonstrated a time-dependent increase, reaching 217 Ϯ 48% (P Ͻ 0.05) of the value in untreated cells after 16 h of melatonin withdrawal (Fig. 6A) . These increases in pertussis toxin-induced ribosylation of G␣ i /G␣ o were not the result of increases in G␣ i1 , G␣ i2 , and G␣ i3 protein levels. No change in levels occurred after pretreatment and withdrawal of melatonin (Fig.  6B) .
Discussion
Activation of the h mt 1 melatonin receptor expressed in CHO cells by melatonin decreases forskolin-induced cAMP formation via pertussis toxin-sensitive and insensitive G proteins (7). The melatonin-mediated inhibition of forskolinstimulated cAMP formation led to decreases in both PKA activity and the phosphorylation of the nuclear CREB protein. This is consistent with the results described for melatonin receptors expressed in the pars tuberalis of the ewe (5, 6, 17) . Furthermore, we demonstrated that the exposure of mt 1 -CHO cells to a physiological concentration of melatonin for a length of time that mimics the period of darkness, i.e. 8 h, induced supersensitization of the cAMP-dependent signaling cascade during the withdrawal period, i.e. potentiation of forskolin-mediated stimulation of cAMP formation, activation of PKA, and phosphorylation of CREB.
In mt 1 -CHO cells, short melatonin exposure inhibited the cAMP-dependent signal transduction pathway, whereas after withdrawal from physiological melatonin exposure, a supersensitization of forskolin-induced cAMP formation, PKA activation, and phosphorylation of CREB were observed. Supersensitization of cAMP-dependent signaling cascades after agonist exposure has been shown for other inhibitory G protein-coupled receptors as well. Prolonged   FIG. 4 . Increase in forskolin-induced PKA activity and phosphorylation of CREB in mt 1 -CHO cells after melatonin withdrawal. mt 1 -CHO cells grown to confluence were exposed to vehicle (control cells; C) or melatonin (400 pM for 8 h). Forskolin (10 M)-stimulated PKA activity (A) or total cAMP-stimulated PKA activity (B) was measured various times after melatonin withdrawal (0, 1, and 16 h). Data represent the mean Ϯ SEM of four independent experiments. All data were analyzed by one-way ANOVA (F 3,12 ϭ 3.619). *, P Ͻ 0.05 compared with the control. C, Forskolin (100 M)-stimulated PCREB nuclear immunoreactivity was quantified at various times after melatonin withdrawal (0, 1, and 16 h). Data represent the mean Ϯ SEM of five independent experiments. All data were analyzed by one-way ANOVA (F 3,16 ϭ 5.529). *, P Ͻ 0.01 compared with the control. activation of somatostatin receptors in anterior pituitary tumor cells by somatostatin for 8 h results in an increase in forskolin-induced cAMP formation with no change in basal cAMP levels, basal adenylyl cyclase activity, or phosphodiesterase activity (18) . Pretreatment of D 2 dopamine receptors in mouse fibroblast Ltk-cells with a D 2 agonist (quinpirole) for 24 h results in increases in basal and forskolin-induced cAMP levels, and in basal and forskolin-induced adenylyl cyclase activity (19) . In addition, agonist exposure of D 2 dopamine receptors expressed in HEK293 or C6 cells increases forskolin-induced cAMP accumulation (20) . Finally, pretreatment of ␣ 2 -adrenoceptors in HT29 human colonic adenocarcinoma cells with an ␣ 2 -adrenoceptor agonist (UK14,304) for up to 1 h results in an increase in forskolinstimulated cAMP formation with no change in phosphodiesterase activity (21) .
Desensitization of the h mt 1 melatonin receptors by melatonin exposure may mediate the increase in forskolininduced cAMP formation after melatonin withdrawal. We previously demonstrated that the h mt 1 melatonin receptor expressed in CHO cells is tightly coupled to G i proteins (7) . However, although desensitization of the h mt 1 melatonin receptor correlated with increases in forskolin-induced cAMP formation in these cells (manuscript in preparation), the mechanisms underlying supersensitization of the adenylyl cyclase signal transduction cascade and receptor desensitization may be independent of one another. Evidence suggests that pretreatment of other G i -coupled receptors with their respective agonists results in supersensitization of adenylyl cyclase signal transduction; however, desensitization of the receptors occurred for some [e.g. somatostatin (18) and D 2 dopamine receptors (19, 20) ], but not all [e.g. ␣ 2 -adrenergic receptor (21)], of the receptors.
Decreases in the levels of G i proteins may underlie the potentiation of forskolin-induced cAMP formation in mt 1 -CHO after melatonin withdrawal (22) . This phenomenon is observed in primary cultures of rat striatal neurons (23) and in rat cardiomyocytes (24) after agonist exposure. In the present study melatonin withdrawal did not alter G␣ s or G␣ i1 , G␣ i2 , and G␣ i3 protein levels in CHO cells as determined using antibodies that recognize G␣ s , G␣ i1 ϭ G␣ i2 Ͼ G␣ i3 . We analyzed all these G proteins even though previous reports demonstrate the existence of only G␣ i2 and G␣ i3 in CHO cells (25, 26) . Pertussis toxin and cholera toxin catalyze ADP ribosylation of the heteromeric, undissociated forms of G i and G s , respectively, and do not affect the free ␣-subunit (27, 28) . Therefore, an increase in ribosylation of G␣ i /G␣ o with no concomitant change in G␣ i1 , G␣ i2 , and G␣ i3 protein levels may suggest an increase in the undissociated (G␣␤␥) state of G i proteins after melatonin withdrawal. A decrease in the dissociated form of G i protein (G␣ i ) may attenuate the inhibitory influence of G␣ i on adenylyl cyclase, resulting in a supersensitization of the cAMP-dependent signal transduction cascade. In reconstituted preparations, G␣ i subunit can inhibit adenylyl cyclases V and VI (29) . The identity of the adenylyl cyclase present in CHO cells, however, has not been determined. Chronic antidepressant treatment increases G protein activation of adenylyl cyclase with no change in levels of total G␣ i protein in the rat cerebral cortex. These results could be also explained by an increase in ternary G␣␤␥ protein complexes (30) .
A direct effect of melatonin treatment on adenylyl cyclase activity could also underlie the increases in forskolininduced cAMP formation after withdrawal. To date, evidence suggests that eight isoforms of adenylyl cyclase may exist even though cloning has revealed the existence of only six isoforms (31, 32) . After agonist exposure, the potency of forskolin to activate specifically adenylyl cyclases I and II is increased in HEK293 cells expressing the D2 (short and long) dopamine receptor compared with that in untreated cells (20) . In contrast, no changes in forskolin-induced activation of adenylyl cyclase occur in rat cerebral cortex slices after Column height represents incorporation of 32 P into the M r 41,000 band quantified by integrating phophorimaging and expressed in arbitrary units. Melatonin pretreatment increases pertussis toxin-catalyzed ADP ribosylation after withdrawal of melatonin for 16 h. All data were analyzed by one-way ANOVA (F 3,8 ϭ 5.531). *, P Ͻ 0.05 compared with control. B, Autoradiographic analysis of immunoblots using specific antibodies against G␣ i . The corresponding band of G␣ i was detected by enhanced and quantitated using Molecular Analyst. Melatonin pretreatment did not alter the amount of G␣ i present in mt 1 -CHO cells.
serotonin exposure even though GppNHp increases adenylyl cyclase (33) . Another mechanism that may underlie the increases in adenylyl cyclase activity is enzyme up-regulation. However, even though a diurnal regulation of adenylyl cyclase I occurs in the rat pineal gland, perhaps through fluctuating cAMP levels (34), this mechanism seems unlikely in mt 1 -CHO cells because melatonin treatment does not increase basal levels of cAMP compared with those in untreated cells after withdrawal (data not shown).
PKA activation is initiated by cAMP binding to the regulatory subunits of the tetrameric enzyme PKA, leading to dissociation of the regulatory subunits from the catalytic subunits (35) . In our system, short exposure of mt 1 -CHO cells to melatonin reduces basal and forskolin-induced activation of PKA, suggesting that melatonin can inhibit cAMP formation, resulting in inhibition of PKA activity. The potentiation of forskolin-stimulated PKA activity observed after melatonin withdrawal is likely to result from the intracellular increases in cAMP induced by forskolin under these conditions. Evidence suggests that the regulatory subunits of PKA exert an inhibitory influence on PKA activity (36) and that cAMP analogs can down-regulate the regulatory subunits of PKA (37) . It is conceivable that treatment with melatonin results in down-regulation of the regulatory subunits of this kinase and decreases the inhibitory influence that these regulatory subunits have on PKA, leading to increased PKA activity. Increases in PKA activity may not result from upregulation of PKA in our model, as total PKA activity was of similar magnitude in both control and melatonin-treated cells.
Treatment of the mt 1 -CHO cells with melatonin resulted in an increase in forskolin-induced phosphorylation of CREB protein compared with that in untreated cells after withdrawal. It is well established that cAMP binds to the tetrameric form of PKA, resulting in a translocation of the dissociated PKA catalytic subunits to the nucleus and phosphorylation of CREB on Ser 133 (35, 38) . The increases in forskolin-induced CREB phosphorylation after melatonin withdrawal may be due to the increase in forskolin-stimulated PKA activity. Up-regulation of CREB protein via cAMP response elements would also explain the potentiation of CREB phosphorylation by forskolin after melatonin withdrawal. However, it is unlikely that this is occurring in mt 1 -CHO cells because basal levels of phosphorylated CREB were not increased (data not shown).
The supersensitization of the adenylyl cyclase signal transduction cascade by 8-h exposure to melatonin reported in this study is the result of mt 1 melatonin receptor-dependent effects. Acute exposure to melatonin (400 pm) did not inhibit phosphorylation of CREB in pSV-Neo CHO cells. After melatonin withdrawal, pSV-Neo CHO cells did not show enhancement of forskolin-induced cAMP accumulation. Additionally, CHO cells transfected with h mt 2 melatonin receptor did not show an increase in forskolin-induced cAMP accumulation (data not shown), again arguing for an mt 1 receptor-specific effect. Therefore, we conclude that this supersensitization phenomenon is specific for the mt 1 receptor transfected into CHO cells and is not the result of intracellular effects of melatonin.
Protein kinase C (PKC) may also be involved in the sensitization process induced by melatonin treatment. For example, phosphorylation of CREB protein has been shown to occur through mechanisms independent of cAMP, i.e. via activation of PKC by serum or PGs (39) . The involvement of PKC in melatonin receptor-mediated signaling has been demonstrated on the firing rate in slices of the suprachiasmatic nucleus (40) . However, although melatonin can modulate PLC-mediated pathways, it has been shown that it does not stimulate phospholipases directly (8, 41) . In our hands, only high concentrations of melatonin (Ն1 nm) stimulated phosphoinositide hydrolysis in mt 1 -CHO cells (data not published). Therefore, because melatonin concentrations less than 1 nm were used in the present studies, and all melatonin pretreatments were performed in F-12 medium without serum, PKC is probably not involved in the supersensitization of the cAMP-dependent cascade in mt 1 -CHO cells. Overall, these results suggest potential functional consequences in h mt 1 melatonin receptor-mediated signaling after withdrawal of melatonin in tissues endowed with these receptors. This study demonstrates that melatonin treatment and withdrawal induce sensitization of cAMP-mediated signaling. As the hormone melatonin is released in a circadian fashion, with peak levels occurring during the night and persisting for approximately 8 h, the results of this study are relevant to explain the functional consequences of the circadian rhythm of melatonin production. It can be speculated that circadian exposure of melatonin receptor to melatonin serves to turn off the inhibitory signal, leading to sensitization of the adenylyl cyclase cascade for stimulatory input by an as yet unidentified signal.
